Pingda Ren

6.2k total citations · 2 hit papers
49 papers, 3.2k citations indexed

About

Pingda Ren is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Pingda Ren has authored 49 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 24 papers in Molecular Biology and 8 papers in Inorganic Chemistry. Recurrent topics in Pingda Ren's work include PI3K/AKT/mTOR signaling in cancer (12 papers), Asymmetric Hydrogenation and Catalysis (8 papers) and Cyclopropane Reaction Mechanisms (6 papers). Pingda Ren is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (12 papers), Asymmetric Hydrogenation and Catalysis (8 papers) and Cyclopropane Reaction Mechanisms (6 papers). Pingda Ren collaborates with scholars based in United States, China and United Kingdom. Pingda Ren's co-authors include Matthew R. Janes, Christian Rommel, Michael Martin, Yi Liu, Huw M. L. Davies, Kevan M. Shokat, Katti Jessen, Lian‐Sheng Li, Shunyou Wang and Davide Ruggero and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Pingda Ren

48 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The translational landscape of mTOR signalling steers cancer initiation and metastasis

2012 978 citations Andrew C. Hsieh, Yi Liu et al. Nature profile →
Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State

2016 530 citations Matthew P. Patricelli, Matthew R. Janes et al. Cancer Discovery profile →

Peers

Countries citing papers authored by Pingda Ren

Since Specialization

Citations

This map shows the geographic impact of Pingda Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingda Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingda Ren more than expected).

Fields of papers citing papers by Pingda Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingda Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingda Ren. The network helps show where Pingda Ren may publish in the future.

Co-authorship network of co-authors of Pingda Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Pingda Ren. A scholar is included among the top collaborators of Pingda Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingda Ren. Pingda Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metal powder atomization preparation, modification, and reuse for additive manufacturing: A review 2025 ·Progress in Materials Science ·Pingda Ren, Yu Ouyang, (unknown), Sheng Luo, Zijue Tang, Yi Wu, Chu Lun Alex Leung, J.P. Oliveira, Yu Zou, Haowei Wang, Hongze Wang, (unknown), (unknown)	14
2	NHC-ligated gold nanoparticles derived from cluster precursors for carbon monoxide oxidation reactions 2025 ·Dalton Transactions ·Xiaoke Feng, Ren Chen, Peiqiong Chen, (unknown), Pingda Ren, (unknown), Yujing Weng, Xi‐Yan Dong	0
3	From Lab Formulation Development to CTM Manufacturing of KO-947 Injectable Drug Products: a Case Study and Lessons Learned 2021 ·AAPS PharmSciTech ·Xiaohu Deng, Pingda Ren, (unknown), Yi Wang, Yuanyang Zhang, Hongbing Wu, (unknown), Huazhen Chen	3
4	The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors 2018 ·Nature Structural & Molecular Biology ·Rasmus Hansen, Ulf Peters, Anjali Babbar, Yuching Chen, Jun Feng, Matthew R. Janes, Lian‐Sheng Li, Pingda Ren, Yi Liu, Patrick P. Zarrinkar	100
5	Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State breakdown → 2016 ·Cancer Discovery ·Matthew P. Patricelli, Matthew R. Janes, Lian‐Sheng Li, Rasmus Hansen, Ulf Peters, Linda Kessler, Yuching Chen, Jeff Kucharski, Jun Feng, Tess Ely, Jeffrey H. Chen, Sarah J. Firdaus, Anjali Babbar, Pingda Ren, Yi Liu	530
6	Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function* 2012 ·Journal of Biological Chemistry ·Lomon So, Sung Su Yea, Jean Oak, Mengrou Lu, (unknown), (unknown), Matthew R. Janes, Linda Kessler, Jeff Kucharski, Lian‐Sheng Li, Michael Martin, Pingda Ren, Katti Jessen, Yi Liu, Christian Rommel, (unknown)	59
7	PI3 Kinase δ Is a Key Regulator of Synoviocyte Function in Rheumatoid Arthritis 2012 ·American Journal Of Pathology ·Beatrix Bartók, David L. Boyle, Yi Liu, Pingda Ren, Scott T. Ball, William D. Bugbee, Christian Rommel, Gary S. Firestein	87
8	The translational landscape of mTOR signalling steers cancer initiation and metastasis breakdown → 2012 ·Nature ·Andrew C. Hsieh, Yi Liu, (unknown), Nicholas T. Ingolia, Matthew R. Janes, (unknown), (unknown), Craig R. Stumpf, (unknown), Michael Bonham, Shunyou Wang, Pingda Ren, Michael Martin, Katti Jessen, Morris E. Feldman, Jonathan S. Weissman, Kevan M. Shokat, Christian Rommel, Davide Ruggero	978
9	Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia 2012 ·Leukemia ·Matthew R. Janes, (unknown), Sharmila Mallya, (unknown), Jose J. Limon, Lian‐Sheng Li, Katti Jessen, Michael Martin, Pingda Ren, Michelle M. Lilly, Leonard S. Sender, Yi Liu, Christian Rommel, (unknown)	85
10	The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors 2010 ·Nature Chemical Biology ·Alex Berndt, Simon Miller, Olusegun Williams, Daniel D. Le, Benjamin T. Houseman, Joseph I. Pacold, F. Gorrec, Wai‐Ching Hon, Pingda Ren, Yi Liu, Christian Rommel, P. Gaillard, Thomas Rückle, Matthias Schwarz, Kevan M. Shokat, Jeffrey P. Shaw, Roger Williams	215
11	Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor 2010 ·Nature Medicine ·Matthew R. Janes, Jose J. Limon, Lomon So, Jing Chen, Raymond J. Lim, (unknown), (unknown), Michelle M. Lilly, Sharmila Mallya, S. Tiong Ong, Marina Konopleva, Michael Martin, Pingda Ren, Yi Liu, Christian Rommel, (unknown)	276
12	A Type-II Kinase Inhibitor Capable of Inhibiting the T315I “Gatekeeper” Mutant of Bcr-Abl 2010 ·Journal of Medicinal Chemistry ·Hwan Geun Choi, Pingda Ren, Francisco Adrián, Fangxian Sun, Hyun Soo Lee, Xia Wang, Qiang Ding, Guobao Zhang, Yongping Xie, Jianming Zhang, Yi Liu, Tove Tuntland, Markus Warmuth, Paul W. Manley, Jürgen Mestan, Nathanael S. Gray, Taebo Sim	58
13	Discovery of pyrimidine benzimidazoles as Src-family selective Lck inhibitors. Part II 2009 ·Bioorganic & Medicinal Chemistry Letters ·Guobao Zhang, Pingda Ren, Nathanael S. Gray, Taebo Sim, Xia Wang, Yi Liu, Jianwei Che, (unknown), (unknown), Mark L. Sandberg, Tracy A. Spalding, Russell D. Romeo, Maya Iskandar, Zhiliang Wang, H. Martin Seidel, Donald S. Karanewsky, Yun He	5
14	Discovery of pyrimidine benzimidazoles as Lck inhibitors: Part I 2008 ·Bioorganic & Medicinal Chemistry Letters ·Guobao Zhang, Pingda Ren, Nathanael S. Gray, Taebo Sim, Yi Liu, Xia Wang, Jianwei Che, (unknown), Mark L. Sandberg, Tracy A. Spalding, Russell D. Romeo, Maya Iskandar, Donald Chow, H. Martin Seidel, Donald S. Karanewsky, Yun He	26
15	A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors 2006 ·Chemistry & Biology ·Okram Barun, A. S. Nagle, Francisco Adrián, Christian Lee, Pingda Ren, Xia Wang, Taebo Sim, Yongping Xie, Xing Wang, Gang Xia, Glen Spraggon, Markus Warmuth, Yi Liu, Nathanael S. Gray	124
16	A Genome-Wide Overexpression Screen in Yeast for Small-Molecule Target Identification 2005 ·Chemistry & Biology ·Hendrik Luesch, Tom Wu, Pingda Ren, Nathanael S. Gray, Peter G. Schultz, František Supek	84
17	Synthesis of iodinated 3β-aryltropanes with selective binding to either the dopamine or serotonin transporters 2002 ·Bioorganic & Medicinal Chemistry Letters ·Huw M. L. Davies, Pingda Ren, Norman Kong, Tammy Sexton, Steven R. Childers	4
18	Synthesis and monoamine transporter affinity of 3β-(4-(2-pyrrolyl)phenyl)-8-azabicyclo[3.2.1]octanes and 3β-(5-Indolyl)-8-azabicyclo[3.2.1]octanes 2001 ·Bioorganic & Medicinal Chemistry Letters ·Huw M. L. Davies, Pingda Ren, Norman Kong, Tammy Sexton, Steven R. Childers	6
19	Reduction of Aromatic α-Halo Ketones with Metallic Bismuth 1997 ·Synthetic Communications ·Pingda Ren, Qihui Jin, (unknown)	3
20	Catalytic Reduction of Nitroarenes to Azoxybenzenes With Sodium Borohydride in the Presence of Bismuth 1996 ·Synthetic Communications ·Pingda Ren, Shifeng Pan, (unknown), Shi‐Hui Wu	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact